Drug
Form 1 OF Azd5718
Form 1 OF Azd5718: highest development phase Phase 1, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Form 1 of AZD5718 tablets NCT03420092 | Phase 1 | Coronary Artery Disease |
Latest
No recent events.
Follow Form 1 OF Azd5718 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.